DNA DAMAGE-INDUCIBLE TRANSCRIPT 4 PROTEIN
UNII Y7J61ZB4MV

Substance Identification & Data

This profile provides standardized clinical and technical data for Dna Damage-inducible Transcript 4 Protein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y7J61ZB4MV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Y7J61ZB4MV
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DNA DAMAGE-INDUCIBLE TRANSCRIPT 4 PROTEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dna Damage-inducible Transcript 4 Protein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DDIT4
DNA DAMAGE-INDUCIBLE TRANSCRIPT 4 PROTEIN
HIF-1 RESPONSIVE PROTEIN RTP801
PROTEIN REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSE 1
REDD-1

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record